Virginia Heart Doctor Trains Nationally Recognized Expert To Implant Device used to Prevent Sudden Cardiac Death
Norfolk, VA (December 14, 2012) – A cardiologist and researcher with Sentara Cardiovascular Research Institute travels today to top-ranked heart center Cleveland Clinic to train its doctors to implant a new defibrillator. As a top enrolling physician in the clinical research study that brought this new S-ICD widely to patients, Allen Ciuffo, M.D. is passing on what he’s learned.
Called an S-ICD or subcutaneous implantable cardioverter defibrillator, the new device gained FDA approval this fall. It’s used to restart hearts in patients with potentially fatal irregular heart beats.
Ciuffo already trained physicians in Boston at Massachusetts General Hospital, ranked 5th in the country for heart care by U.S. News & World Report 2012-2013 and Brigham and Women’s Hospital, ranked 9th.
Sentara began enrolling patients in the study October 2011 to evaluate the investigational device. First to sign up through Sentara was 35-year-old Lisa Callis Williams. She’d been faced with the possibility of having a life threatening incident for most of her life. At age nine, her older brother collapsed and died while they were playing outside together. In 2005, Williams was diagnosed with the same condition as her brother and sought out centers involved in the study as an option. Now this device is available to more patients following FDA approval.
Sentara Cardiovascular Research Institute
Massachusetts General Hospital
Brigham and Women’s Hospital
For more health information and the latest news, visit Sentara News or follow us on Facebook and Twitter.